No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Boronic Acids / adverse effects*
-
Bortezomib
-
Gene Expression Profiling
-
Gene Frequency
-
Genetic Predisposition to Disease
-
Humans
-
Multiple Myeloma / diagnosis
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / genetics
-
Neoplasm Staging
-
Peripheral Nervous System Diseases / chemically induced*
-
Peripheral Nervous System Diseases / genetics
-
Polymorphism, Single Nucleotide
-
Pyrazines / adverse effects*
-
Risk Assessment
-
Risk Factors
-
Time Factors
-
Treatment Outcome
-
Vincristine / adverse effects*
Substances
-
Antineoplastic Agents
-
Boronic Acids
-
Pyrazines
-
Vincristine
-
Bortezomib